Monday, September 9, 2013

Additional Details on the MERS-CoV Family Cluster from Hafar Al-Batin, Saudi Arabia



A family cluster of Middle East respiratory syndrome coronavirus (MERS-CoV) has been reported from Hafar Al-Batin in northern Saudi Arabia. Five these individuals have been reported to World Health Organization (WHO) by the Kingdom of Saudi Arabia Ministry of Health (MOH). There is uncertainty surrounding the family relationships among these infected individuals however Arabic media reports (noted below) allow a tentative construction of the kinship relations among these cases as depicted below. According to the reconstruction, 3 generations in this family have been infected with the disease.

Besides this family cluster, the Saudi MOH is reporting four other MERS-CoV cases from Hafar Al-Batin that may be associated with this family cluster. Three of the other four cases as noted below are reported to have had contact with MERS-CoV infected individuals. 


Family relationships of this cluster are reported at FluTrackers.

The five cases reported by WHO (age sex, status)

38 M, died, onset August 8, 2013, died August 17, 2013

79 F, August 21, 2013, died September 2, 2013

47 M, onset August 23, 2013, in ICU

16 M, asymptomatic

7 F, asymptomatic

Additional MERS-CoV cases from Hafar Al-Batin from Saudi Arabia MOH reports (age, sex, status)

74 F,  in ICU

74 F, died, contact with other cases

18 ?, asymptomatic, contact with other cases

3 F, asymptomatic, contact with other cases
link: http://www.flutrackers.com/forum/showpost.php?p=508937&postcount=1


Friday, September 6, 2013

The High Cost of Recovering From an A(H7N9) Infection


Influenza A(H7N9) has infected more than 130 people in the People’s Republic of China. It is a severe disease; more than 40 individuals have died. Those individuals that do survive often require long hospital stays including many days in an intensive care unit (ICU). Hospitalization in ICUs is expensive.
For example, the first A(H7N9) case from Guangdong Province, spent 20 days in ICU,  with the hospital costs totaling about 220,000 yuan [1]. In China, the average annual wage is 42,000 yuan.[2] Putting the hospitalization cost for A(H7N9) for this patient in perspective, it would take an average individual in China more than five years to pay off this cost providing 100% of the salary went to pay the hospital bill. 
This individual is not an isolated case. Based on limited publicly available data, 28 of the individuals infected with A(H7N9) from China who recovered were hospitalized between 6-30+ days, with a median hospital stay of 18 days, although not all of them were treated in the ICU. Information is available on 23 of the individuals in China who died from A(H7N9). These 23 individuals were treated in the hospital between 2-30+ days before death, with a median hospital stay of 11 days among these individuals who died. What these statistics indicate is that extended hospital treatment is required for most A(H7N9) patients, up to 30 days with no guarantee of recovery. These data also suggest the extraordinary costs being absorbed by Chinese government to treat these infected individuals. 

Comparison with the USA
 
In an article published in 2012 in the Annals of Intensive Care, the authors studied the total hospitalization cost for various categories of patients including 23 Influenza A(H1N1)pdm09 patients from Cleveland, Ohio.[3] The total hospital costs in Cleveland in 2009-2010 for treating influenza patients in intensive care units averaged about  $342,000, about 6.5 times the median annual household income ($52,700) in the USA.[4]
ICU care is comparatively expensive both in China and the US and is primarily related to occurrence of acute respiratory distress syndrome (ARDS). ARDS is among the most expensive conditions encountered in the ICU. [4]  ARDS is also  a common occurrence in individuals infect with novel influenza A(H5N1) and A(H7N9). In fact, a recent study of A(H7N9) patients from Zhejiang Province in China showed that 100% of the cases had complications from ARDS.[5]
If a novel influenza pandemic breaks out, many sick individuals will require extended hospital care in ICUs. The cost of this care to governments and health insurance companies will be enormous. The more ominous concern is that if a new influenza pandemic occurs, there will simply not be enough medical facilities to care for all the individuals that may need hospitalization regardless of whether an individual can pay or not. 
 
[1] Guangdong's first H7N9 patient can be discharged next week, nearly 220,000 yuan treatment fee  h/t Pathfinder
[2] Average wages in China
[3] Relative cost and outcomes in the intensive care unit of acute lung injury (ALI) due to pandemic influenza compared with other etiologies: a single-center study [4] US Census Bureau Quick Facts
[5] Epidemiological, clinical and viral characteristics of fatal cases of human avian influenza A (H7N9) virus in Zhejiang Province, China

Thursday, September 5, 2013

MERS-CoV Cluster: Three Generations in One Family Infected with MERS-CoV, Hafar Al-Batin, Saudi Arabia



Middle East Respiratory Coronavirus (MERS-CoV) is reported to have infected a family cluster of three generations in Hafar Al-Batin in the Kingdom of Saudi Arabia (KSA) (see map below). Hafar Al-Batin is a city in the Eastern Province (ash-SharqÄ«yah) of KSA with a population of almost 400,000 people.[1] Official information from the KSA Ministry of Health is lacking on this cluster, however, scattered Arabic language media reports from the region allow a tentative reconstruction of this cluster of at least 4 cases. Other MERS-CoV cases are reported from Hafar Al-Batin, including a health care worker. Some of these other cases may be associated with this cluster.  Each of the cases in the cluster is described below. 



A. 60-70?, F died (within the past few days), newly reported, not confirmed by World Health Organization (WHO). [2] 

B. Fahad Al-Sahli, 38, M  died (Aug 17 or 18, 2013), son of Case A.   Confirmed by WHO.  [3]
 
C. 7 (8?), F reported recovered, granddaughter of Case A, may be daughter or niece of Case B. Confirmed by WHO. [3]

D. 16, M reported recovered,  grandson of Case A and may be son or nephew of Case B. Confirmed by WHO. [3]
 
No information is available for the onset dates, hospitalization dates, the physical residence of each of the individual, or contact details.   It is extremely unlikely that all of these family members were infected from an unidentified animal host.  It is much more likely this cluster is a result of human-to-human transmission than exposure to a common animal reservoir.






  

Thursday, August 29, 2013

Pigs as mixing vessels for novel pandemic influenza viruses



In an article to be published in the journal Microbial Pathogenesis, Chinese researchers report on a 4 year serological surveillance project of Influenza A on pigs farms in  Guangdong, Zhejiang, Fujian, and Yunnan Provinces in Southern China.[1] As the authors note, pigs are believe to be intermediate hosts or mixing vessels of pandemic influenza viruses. Influenza viruses can undergo reassortment in pigs, allowing the virus to adapted to humans and possibly cause a pandemic.

The serological study used haemagglutination inhibition (HI) tests to examine antibodies of H5 and H9 viruses among the samples from pigs. The good news is that the researchers failed to find H5 infections (Clade 2.3.2) within the pig samples. A ressortant H5N1 virus from pigs could easily start the next pandemic. H5 viruses have already infected more than 600 people from numerous countries in the last decade, so an H5N1 pandemic is a serious concern.

The bad news is that the authors found an infection rate of at least 3.7% among the samples from pigs for H9 viruses. H9 viruses also pose a pandemic threat for humans. Another serological study from 2009 in China found that a small percentage of farmers  from Xinjiang Uygur autonomous region and Liaoning province tested positive for H9 viruses.[2] A reassortant pandemic virus  does not have to originate in a pig, it could originate in a human infected with  H9 or H5 viruses.